Research Funding
- NIH Director's Early Independence Award
- NIH Director's New Innovator Award
- NIH Director's Pioneer Award
- NIH Director's Transformative Research Award
- Illuminating the Druggable Genome
- Somatic Cell Genome Editing
- Stimulating Peripheral Activity to Relieve Conditions (SPARC)
High-Risk Research: NIH Director's Early Independence Award Program
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| 2019 NIH Director's Early Independence Award (DP5) | 3/26/2018 | RFA-RM-18-010 | Ravi Basavappa earlyindependence@mail.nih.gov (301) 435-7204 |
Letter of Intent: 8/27/2018 Receipt Date: 9/27/2018 |
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | 1/25/2018 | PA-18-586 | Ravi Basavappa earlyindependence@mail.nih.gov (301) 435-7204 |
|
| Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) | 1/25/2018 | PA-18-592 | Ravi Basavappa earlyindependence@mail.nih.gov 301 435-7204 |
High-Risk Research: NIH Director's New Innovator Award Program
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| NIH Director's New Innovator Award Program (DP2) | 5/23/2018 | RFA-RM-18-008 | Ravi Basavappa NewInnovatorAward@mail.nih.gov (301) 435-7204 |
9/10/2018 |
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | 1/25/2018 | PA-18-586 | Ravi Basavappa NewInnovatorAward@mail.nih.gov (301) 435-7204 |
|
| Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) | 1/25/2018 | PA-18-592 | Ravi Basavappa NewInnovatorAward@mail.nih.gov 301 435-7204 |
High-Risk Research: NIH Director's Pioneer Award Program
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| 2019 NIH Director's Pioneer Award Program (DP1 Clinical Trial Optional) | 4/23/2018 | RFA-RM-18-007 | Dr. Ravi Basavappa PioneerAwards@mail.nih.gov 301 435-7204 |
9/14/2018 |
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | 1/25/2018 | PA-18-586 | Ravi Basavappa PioneerAwards@mail.nih.gov (301) 435-7204 |
|
| Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) | 1/25/2018 | PA-18-592 | Ravi Basavappa PioneerAwards@mail.nih.gov 301 435-7204 |
High-Risk Research: NIH Director's Transformative Award Program
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| NIH Director's Transformative Research Awards (R01) | 5/23/2018 | RFA-RM-18-009 | Ravi Basavappa Transformative_Awards@mail.nih.gov (301) 435-7204 |
9/21/2018 |
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | 1/25/2018 | PA-18-586 | Ravi Basavappa Transformative_Awards@mail.nih.gov (301) 435-7204 |
|
| Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) | 1/25/2018 | PA-18-592 | Ravi Basavappa Transformative_Awards@mail.nih.gov (301) 435-7204 |
Illuminating the Druggable Genome
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| Cutting Edge Informatics Tools for Illuminating the Druggable Genome (U01 Clinical Trial Not Allowed) | 4/3/18 | RFA-RM-18-011 | Jean C. Zenklusen jz44m@nih.gov 240-781-3409 |
Letter of Intent: 6/9/2018 Receipt Date: 7/9/2018 |
Somatic Cell Genome Editing
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| Large Animal Testing Centers for Evaluation of Somatic Cell Genome Editing Tools (U42 - Clinical Trial Not Allowed) | 6/12/2018 | RFA-RM-18-014 | Oleg Mirochnitchenko oleg.mirochnitchenko@nih.gov 301-435-0748 |
Letter of Intent: 7/24/2018 Receipt Date: 8/24/2018 |
Stimulating Peripheral Activity to Relieve Conditions (SPARC)
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| Notice of Intent to Publish a Funding Opportunity Announcement for SPARC Clinical Studies of Peripheral and Spinal Neuromodulation Devices to Support New Indications and Human Functional Mapping (OT2 Clinical Trial Required) | 3/2/2018 | NOT-RM-18-012 | Danilo A. Tagle SPARC_TPNI@mail.nih.gov 301-594-8064 |
N/A |
Past Funding Opportunities
• 4D Nucleome
• Big Data to Knowledge
• Bioinformatics and Computational Biology
• Bridging Interventional Development Gaps (BrIDGs)
• Building Blocks, Biological Pathways and Networks
• Enhancing the Diversity of the NIH-Funded Workforce
• Epigenomics
• Extracellular RNA Communication
• Genotype-Tissue Expression (GTEx)
• Global Health
• Glycoscience
• Gulf Oil Spill
• HCS Research Collaboratory
• Health Economics
• High-Risk Research:
• NIH Director’s Early Independence Award (EIA)
• NIH Director’s New Innovator Award
• NIH Director’s Pioneer Award
• NIH Director’s Transformative Research Awards
• Human Microbiome Project
• Illuminating the Druggable Genome
• Interdisciplinary Research
• Knockout Mouse Phenotyping
• Library of Integrated Network-Based Cellular Signatures (LINCS)
• Metabolomics
• Molecular Libraries and Imaging
• Nanomedicine
• NIH Center for Regenerative Medicine (NIH CRM)
• NIH Medical Research Scholars Program
• PROMIS: Patient-Reported Outcomes Measurement Information System
• Protein Capture Reagents
• Regulatory Science
• Science of Behavior Change
• Single Cell Analysis
• Stimulating Peripheral Activity to Relieve Conditions (SPARC)
• Strengthening the Biomedical Research Workforce
• Structural Biology
• Undiagnosed Diseases
Funded Research
• 4D Nucleome
• Big Data to Knowledge
• Bioinformatics and Computational Biology
• Bridging Interventional Development Gaps (BrIDGs)
• Building Blocks, Biological Pathways and Networks
• Enhancing the Diversity of the NIH-Funded Workforce
• Epigenomics
• Extracellular RNA Communication
• Gabriella Miller Kids First
• Genotype-Tissue Expression (GTEx)
• Global Health
• Glycoscience
• HCS Research Collaboratory
• Health Economics
• High-Risk Research:
• NIH Director’s Early Independence Award (EIA)
• NIH Director’s New Innovator Award
• NIH Director’s Pioneer Award
• NIH Director’s Transformative Research Awards
• Human Microbiome Project
• Illuminating the Druggable Genome
• Interdisciplinary Research
• Knockout Mouse Phenotyping
• Library of Integrated Network-Based Cellular Signatures (LINCS)
• Metabolomics
• Molecular Libraries and Imaging
• Molecular Transducers of Physical Activity in Humans
• Nanomedicine
• NIH Center for Regenerative Medicine (NIH CRM)
• NIH Medical Research Scholars Program
• PROMIS: Patient-Reported Outcomes Measurement Information System
• ProteinCapture Reagents
• Regulatory Science
• Science of Behavior Change
• Single Cell Analysis
• Stimulating Peripheral Activity to Relieve Conditions (SPARC)
• Strengthening the Biomedical Research Workforce
• Structural Biology
• Undiagnosed Diseases
This page last reviewed on June 18, 2018